Abstract
This paper assesses whether chemically dependent adolescents with comorbid learning disorders (LDs) derived less effective treatment results when compared to chemically dependent adolescents without LD and examines the moderating effects of prior treatments, treatment length, and treatment completion. Two hundred one adolescents were recruited between 1992 and 1993 from Massachusetts residential treatment centers and subsequently followed up 6 months after enrollment. Compared to chemically dependent teenagers without LD, those with LD were twice as likely to re-use substances at least once by follow-up. LD teenagers were more likely to attend Alcoholics/Narcotics Anonymous if they had prior admissions to treatment programs and longer treatment length. LD teenagers who completed treatment also experienced a greater decrease in current depression compared to LD teenagers not completing the treatment. This study is the first to consider outcomes of substance abuse treatment for adolescents with LD and contributes to the growing literature on comorbidity and substance abuse treatment.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11414-006-9023-5/MediaObjects/11414_2006_9023_Fig1_HTML.gif)
Similar content being viewed by others
References
Center on Addiction and Substance Abuse (CASA) at Columbia University. Substance Abuse and Learning Disabilities: Peas in a Pod or Apples and Oranges? New York: The National Center of Addiction and Substance Abuse; 2000.
Rhodes SS, Jasinski DR. Learning disabilities in alcohol-dependent adults: a preliminary study. Journal of Learning Disabilities. 1990;23:551–556.
Jaycox LH, Morral AR, Juvonen J. Mental health and medical problems and service use among adolescent substance users. Journal of the American Academy of Child and Adolescent Psychiatry. 2003;42:701–709.
Kaminer Y, Burleson JA, Goldberger R. Cognitive-behavioral co** skills and psychoeducation therapies for adolescent substance abuse. Journal of Nervous and Mental Disease. 2002;190:737–745.
Bovasso G. The long-term treatment outcomes of depression and anxiety comorbid with substance abuse. Journal of Behavioral Health Services and Research. 2001;28:42–57.
Gonzalez G, Rosenheck RA. Outcomes and service use among homeless persons with serious mental illness and substance abuse. Psychiatric Services. 2002;53:437–451.
Staines G, Magura S, Rosenblum A, et al. Predictors of drinking outcomes among alcoholics. American Journal of Drug and Alcohol Abuse. 2003;29:203–218.
Karacostas DD, Fisher GL. Chemical dependency in students with and without learning disabilities. Journal of Learning Disabilities. 1993;26:491–495.
Shaywitz B, Fletcher J, Shaywitz S. Attention-deficit/hyperactivity disorder. In: Swaiman K, Ashwal S, eds. Pediatric Neurology: Principles and Practice. St. Louis: CV Mosby; 1997:585–597.
Deb S, Thomas M, Bright C. Mental disorder in adults with intellectual disability: the rate of behaviour disorders among a community-based population aged between 16–64 years. Journal of Intellectual Disability Research. 2001;45:506–514.
Bruck M. Social and emotional adjustments of learning disabled children: a review of the issues. In: Ceci S, ed. Handbook of Cognitive, Social, and Neuropsychological Aspects of Learning Disabilities. Hillsdale, NJ: Erlbaum; 1986:230–250.
Wise BK, Cuffe SP, Fischer T. Dual diagnosis and successful participation of adolescents in substance abuse treatment. Journal of Substance Abuse Treatment. 2001;21:161–165.
Campbell JA, Essex EL, Held G. Issues in chemical dependency treatment and aftercare for people with learning differences. Health and Social Work. 1994;19:63–70.
Koegel L, Harrower J, Koegel R. Support for children with developmental disabilities in full inclusion classrooms through self-management. Journal of Positive Behavior Interventions. 1999;1:26–34.
Dodge R, Sindelar J, Sinha R. The role of depression symptoms in predicting drug abstinence in outpatient substance abuse treatment. Psychiatric Clinics of North America. 2003;26:381–409.
Hser YI, Grella CE, Hubbard RL, et al. An evaluation of drug treatments for adolescents in 4 US cities. Archives of General Psychiatry. 2001;58:689–695.
Ciraulo DA, Piechniczek-Buczek J, Iscan EN. Outcome predictors in substance use disorders. Psychiatric Clinics of North America. 2003;26:381–409.
White AM, Jordan JD, Schroeder KM, et al. Predictors of relapse during treatment and treatment completion among marijuana-dependent adolescents in an intensive outpatient substance abuse program. Substance Abuse. 2004;25:53–59.
Horgan C, Skwara K, Strickler G. Substance Abuse. The Nation's Number One Health Problem. Princeton, NJ: The Robert Wood Johnson Foundation; 2001.
Whitmore EA, Mikulich SK, Ehlers KM, et al. One-year outcome of adolescent females referred for conduct disorder and substance abuse/dependence. Drug and Alcohol Dependence. 2000;59:131–141.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition—Revised. Washington DC: American Psychiatric Association; 1987.
Deykin EY, Buka SL. Prevalence and risk factors for posttraumatic stress disorder among chemically dependent adolescents. American Journal of Psychiatry. 1997;154:752–757.
Wechsler D. Wechsler Intelligence Scale for Children. New York: Psychological Corporation; 1991.
Jastak J, Wilkenson G. Wide Range Achievement Test. Wilmington, DE: Wide Range Inc; 1993.
United States Office of Education. Rules and regulations implementing public law 94-142 (The Education for All Handicapped Children Act of 1975). 1977:42.65082.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington DC: American Psychiatric Association; 1994.
Stratton J, Gailfus D. A new approach to substance abuse treatment: Adolescents and adults with ADHD. Journal of Substance Abuse Treatment. 1998;15:89–94.
Rutter M, Yule W. The concept of specific reading retardation. Journal of Child Psychology and Psychiatry. 1975;16:181–197.
Winters K, Henly G. Adolescent Diagnostic Interview Manual. Los Angeles: Western Psychological Services; 1993.
Goodman E, Huang B. Socioeconomic status, depressive symptoms, and adolescent substance use. Archives of Pediatric and Adolescent Medicine. 2002;156:448–453.
Grella CE, Hser YI, Vandan J, et al. Drug treatment outcomes for adolescents with comorbid mental and substance use disorders. The Journal of Nervous and Mental Disease. 2001;189:384–392.
Lerner JW. Educational interventions in learning disabilities. Journal of the American Academy of Child and Adolescent Psychiatry. 1989;28:326–331.
Diamond G, Godley SH, Liddle HA, et al. Five outpatient treatment models for adolescent marijuana use. A description of the Cannabis youth treatment interventions. Addiction. 2002;97:70–83.
Ley A, Jeffrey DP, McLaren S, et al. Treatment programmes for people with both severe mental illness and substance misuse. Cochrane Reviews. 2000;4:CD001088.
Carnine D. Teaching complex content to learning disabled students: The role of technology. Exceptional Children. 1989;55:524–533.
Acknowledgments
This research was supported by the Agency for Healthcare Research and Quality (5 T32 HS000086), the Maternal and Child Health Bureau (5T76 MC 00001), the National Institute on Drug Abuse (DA-05834), and the W.T. Grant Foundation (86-1079-86).
Author information
Authors and Affiliations
Corresponding author
Additional information
Stephen L. Buka, ScD, is an associate professor in the Department of Society, Human Development and Health and the Department of Epidemiology, Harvard School of Public Health, 677 Huntington Ave., Boston, MA 02115, USA. Phone: +1-617-4323870. Fax: +1-617-4323755. E-mail: sbuka@hsph.harvard.edu.
Garrett M. Fitzmaurice, ScD, is an associate professor in the Department of Biostatistics and Division of General Medicine, Brigham and Women’s Hospital, 1620 Tremont St., Boston, MA 02120, USA. Phone: +1-617-5257508. Fax: +1-617-4325619. E-mail: fitzmaur@hsph.harvard.edu.
Marie C. McCormick, MD, ScD, is a professor in the Department of Society, Human Development and Health, Harvard School of Public Health, 677 Huntington Ave., Boston, MA 02115, USA. Phone: +1-617-4323759. Fax: +1-617-4323755. E-mail: mmccormi@hsph.harvard.edu
Appendix
Appendix
Sample size (n) for prior admissions, treatment length, and treatment completion for treatment outcomes by LD groups
Outcomes | LD (n) | No LD (n) |
Effect modifiers | ||
Substance re-use | ||
Prior admissions | 14 | 34 |
Treatment length >3 months | 12 | 21 |
Treatment completion | 8 | 25 |
AA/NA Attendance 1+ per week | ||
Prior admissions | 13 | 44 |
Treatment length >3 months | 11 | 42 |
Treatment completion | 8 | 44 |
Pre-treatment arrests | ||
Prior admissions | 19 | 59 |
Treatment length >3 months | 20 | 60 |
Treatment completion | 13 | 76 |
Post-treatment arrests | ||
Prior admissions | 5 | 18 |
Treatment length >3 months | 3 | 6 |
Treatment completion | 2 | 15 |
Pre-treatment depression | ||
Prior admissions | 10 | 33 |
Treatment length >3 months | 7 | 33 |
Treatment completion | 8 | 22 |
Post-treatment depression | ||
Prior admissions | 9 | 30 |
Treatment length >3 months | 5 | 24 |
Treatment completion | 3 | 19 |
Rights and permissions
About this article
Cite this article
Yu, J.W., Buka, S.L., Fitzmaurice, G.M. et al. Treatment Outcomes for Substance Abuse among Adolescents with Learning Disorders. JBHSR 33, 275–286 (2006). https://doi.org/10.1007/s11414-006-9023-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11414-006-9023-5